Genocea Biosciences (GNCA) - Shares outstanding

Number of shares outstanding in March 2022 : 71,120,000

According to Genocea Biosciences 's latest financial reports and stock price the company's current number of shares outstanding is 71,120,000. At the end of 2022 the company had 71,120,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Genocea Biosciences from 2019 to 2022

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2022	71.12 M	1.02%
2021	70.4 M	8.94%
2020	64.62 M	133.98%
2019	27.62 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Agenus AGEN	21,550,000	-69.70%	🇺🇸 USA
Novavax NVAX	160,049,000	125.04%	🇺🇸 USA
Merck MRK	2,532,030,145	3,460.22%	🇺🇸 USA
iBio IBIO	8,633,000	-87.86%	🇺🇸 USA
Pfizer PFE	5,667,000,000	7,868.22%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for Genocea Biosciences (GNCA)

Number of shares outstanding in March 2022 : 71,120,000